Modern vaccine, leaflet: second dose, symptoms, side effects

The Moderna vaccine in the spotlight after the episode of Report on the third dose of the drug. Moderna, one of two Pfizer-powered mRna vaccines, is used as a third dose and booster for categories that have already completed the vaccination course. What is the vaccine leaflet? What are the symptoms and side effects? Faced with the increase in “reports of side effects such as myocarditis and pericarditis” reported by some countries, the EMA assured that it would evaluate “the new data to determine if it is necessary to update the current recommendations in the product information”. “In July 2021 – recalled by the European Medicines Agency – the PRAC concluded that myocarditis and pericarditis, inflammatory heart conditions, can occur in very rare cases after vaccination with Comirnaty or Spikevax, more often after the second dose and in younger men “. For this “the committee recommended listing both conditions as side effects in the product information for these vaccines, along with a warning to raise awareness among health professionals and people receiving these vaccines. Health care professionals also received a notice” in Now, the EU regulatory body continued, “the Prac’s conclusions are supported by new analyzes of data from Nordic countries (Denmark, Finland, Norway and Sweden), which show myocarditis occurs more frequently after the second dose by Comirnaty and Spikevax “. But “preliminary analyzes” also suggest “the possibility that the risk of myocarditis in younger men may be higher after a second dose of Spikevax than after a second dose of Comirnaty, although further evaluation of the data is required”. Moderna vaccine and third dose Third dose anti Covid vaccine, the Ministry of Health has given the green light to the recall of the vaccine with Moderna’s Spikevax with half a dose of the drug, after yesterday’s opinion of the Technical Scientific Commission (Cts) of Aifa. The ok of the organ of the Medicines Agency is contained in a circular, signed by the general director of Health Prevention of the Ministry of Health, Giovanni Rezza, which states that “it is also possible to use the vaccine (Moderna) as a reminder of a primary vaccination course “. It should be noted that” the ‘booster’ dose of the Spikevax vaccine is 50 mcg in 0.25 ml, corresponding to half the dose of that used for the primary course “. used after at least 6 months from the completion of the primary vaccination cycle, regardless of the vaccine previously used, in favor of subjects “for whom the third dose is currently authorized.